3 results
Approved WMOCompleted
* To investigate the effect of roflumilast 500 µg tablets once daily versus placebo on exacerbation rate, and pulmonary function and major adverse cardiovascular events (MACE) in COPD patients who are concomitantly treated with a fixed combination…
Approved WMORecruiting
The aim of this study is to examine whether roflumilast improves cognition in clinical patients with MCI or mild dementia.
Approved WMORecruiting
The objective is to validate the effects of chronic roflumilast treatment on cognitive function (i.e. episodic memory) by means of behavioral tasks, in people suffering from cognitive impairments at least 1 year after stroke.